Allarity stock dips ahead of 1-for-35 reverse stock split
cemagraphics
- Allarity Therapeutics (NASDAQ:ALLR) plans to undertake a 1-for-35 reverse stock split, effective post market on March 24.
- The company's common stock will begin trading on a post split-adjusted basis on March 27.
- The reverse stock split is being undertaken to be in compliance with Nasdaq's listing rule of minimum share price, and to help Allarity's efforts to raise additional capital, the company added.
- Allarity stockholders approved the proposal for the reverse stock split at a meeting held on March 20.
- ALLR -7.08% to $0.11 premarket March 24